Neoantigens in Hematologic Malignancies

Melinda A. Biernacki(Fred Hutch Cancer Center), Marie Bleakley(Unknown)

Frontiers in Immunology

February 14, 2020

10.3389/fimmu.2020.00121

Cited by 42

Related Papers

CBFB-MYH11 fusion neoantigen enables T cell recognition and killing of acute myeloid leukemia

|Journal of Clinical Investigation|2020|111

Minor Histocompatibility Antigen-Specific T Cells

|Frontiers in Pediatrics|2020|32

HA-1–targeted T-cell receptor T-cell therapy for recurrent leukemia after hematopoietic stem cell transplantation

|Blood|2024|29

Phase I Study of Adoptive Immunotherapy with HA-1-Specific CD8+ and CD4+ Memory T Cells for Children and Adults with Relapsed Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation (HCT): Trial in Progress

|Blood|2020|6

Post Hematopoietic Cell Transplantation Maintenance Therapy with Low-Dose Azacitidine in a Pediatric Population with High-Risk Myeloid Neoplasms

|Blood|2023|0